10x Genomics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
10x Genomics, Inc. (TXG) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $26.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $26.17M, a 5.64% decline year-over-year.
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $22.61M, a 26.05% decline year-over-year.
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $25.24M, a 25.51% decline year-over-year.
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $27.74M, a 27.94% decline year-over-year.
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $108.67M, a 22.85% decline from fiscal 2024.
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $140.87M, a 15.65% decline from fiscal 2023.
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $167.01M, a 21.72% increase from fiscal 2022.
- 10x Genomics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $137.21M, a 42.68% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.17M 10-Q · filed 2026-08-07 | $48.78M derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $22.61M 10-Q · filed 2026-08-07 | |||
| 2025-12-31 | $108.67M 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $25.24M 10-Q · filed 2025-11-07 | $52.97M derived: sum of 2 quarters · filed 2026-08-07 | $83.55M derived: sum of 3 quarters · filed 2026-08-07 | |
| 2025-06-30 | $27.74M 10-Q · filed 2026-08-07 | $58.31M derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $30.57M 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $140.87M 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $33.88M 10-Q · filed 2025-11-07 | $72.37M derived: sum of 2 quarters · filed 2025-11-07 | $108.50M derived: sum of 3 quarters · filed 2025-11-07 | |
| 2024-06-30 | $38.49M 10-Q · filed 2025-11-07 | $74.62M derived: sum of 2 quarters · filed 2025-11-07 | ||
| 2024-03-31 | $36.13M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $167.01M 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $40.23M 10-Q · filed 2024-10-29 | $85.96M derived: sum of 2 quarters · filed 2024-10-29 | $128.09M derived: sum of 3 quarters · filed 2024-10-29 | |
| 2023-06-30 | $45.72M 10-Q · filed 2024-10-29 | $87.86M derived: sum of 2 quarters · filed 2024-10-29 | ||
| 2023-03-31 | $42.13M 10-Q · filed 2024-10-29 | |||
| 2022-12-31 | $137.21M 10-K · filed 2025-02-13 | |||
| 2022-09-30 | $33.65M 10-Q · filed 2023-11-03 | $70.06M derived: sum of 2 quarters · filed 2023-11-03 | $96.20M derived: sum of 3 quarters · filed 2023-11-03 | |
| 2022-06-30 | $36.42M 10-Q · filed 2023-11-03 | $62.56M derived: sum of 2 quarters · filed 2023-11-03 | ||
| 2022-03-31 | $26.14M 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | $96.17M 10-K · filed 2024-02-15 | |||
| 2021-09-30 | $25.95M 10-Q · filed 2022-11-03 | $52.88M derived: sum of 2 quarters · filed 2022-11-03 | $69.14M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $26.93M 10-Q · filed 2022-11-03 | $43.19M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $16.25M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $49.47M 10-K · filed 2023-02-16 | |||
| 2020-09-30 | $13.78M 10-Q · filed 2021-11-05 | $27.70M derived: sum of 2 quarters · filed 2021-11-05 | $34.42M derived: sum of 3 quarters · filed 2021-11-05 | |
| 2020-06-30 | $13.92M 10-Q · filed 2021-11-05 | $20.64M derived: sum of 2 quarters · filed 2021-11-05 | ||
| 2020-03-31 | $6.72M 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $13.33M 10-K · filed 2022-02-18 | |||
| 2019-09-30 | $3.87M 10-Q · filed 2020-11-12 | $6.90M derived: sum of 2 quarters · filed 2020-11-12 | $8.26M derived: sum of 3 quarters · filed 2020-11-12 | |
| 2019-06-30 | $3.02M 10-Q · filed 2020-11-12 | $4.38M derived: sum of 2 quarters · filed 2020-11-12 | ||
| 2019-03-31 | $1.36M 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $2.66M 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $589.00K 10-Q · filed 2019-11-12 | $1.11M derived: sum of 2 quarters · filed 2019-11-12 | $1.59M derived: sum of 3 quarters · filed 2019-11-12 | |
| 2018-06-30 | $518.00K 10-Q · filed 2019-11-12 | $1.01M derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-03-31 | $488.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $1.66M 10-K · filed 2020-02-27 |